Glucagon-like peptide-1 (GLP-1) agonists, Dipeptidyl Peptidase-4 (DPP-4) inhibitors, Sodium-Glucose Transport Protein-2 (SGLT2) inhibitors, myoinositol, thyroid hormones, and vitamin supplements are among the new and forthcoming treatments for PCOS. The gene discussed is DPP4; the disease is polycystic ovary syndrome.